Logo image of DMYY

DMY SQUARED TECHNOLOGY GR-A (DMYY) Stock Fundamental Analysis

NYSEARCA:DMYY - NYSE Arca - US2332761046 - Common Stock - Currency: USD

11.09  +0.06 (+0.54%)

After market: 11.15 +0.06 (+0.54%)

Fundamental Rating

1

Taking everything into account, DMYY scores 1 out of 10 in our fundamental rating. DMYY was compared to 0 industry peers in the Unkown industry. DMYY may be in some trouble as it scores bad on both profitability and health. DMYY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DMYY has reported negative net income.
In the past year DMYY has reported a negative cash flow from operations.
DMYY Yearly Net Income VS EBIT VS OCF VS FCFDMYY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 1M -1M 2M -2M

1.2 Ratios

Industry RankSector Rank
ROA 1.2%
ROE 1.61%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DMYY Yearly ROA, ROE, ROICDMYY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 2 -2 -4

1.3 Margins

DMYY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DMYY Yearly Profit, Operating, Gross MarginsDMYY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for DMYY remains at a similar level compared to 1 year ago.
Compared to 1 year ago, DMYY has an improved debt to assets ratio.
DMYY Yearly Shares OutstandingDMYY Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M
DMYY Yearly Total Debt VS Total AssetsDMYY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M

2.2 Solvency

DMYY has an Altman-Z score of 3.42. This indicates that DMYY is financially healthy and has little risk of bankruptcy at the moment.
DMYY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 3.42
ROIC/WACCN/A
WACCN/A
DMYY Yearly LT Debt VS Equity VS FCFDMYY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M 40M 60M

2.3 Liquidity

DMYY has a Current Ratio of 0.16. This is a bad value and indicates that DMYY is not financially healthy enough and could expect problems in meeting its short term obligations.
DMYY has a Quick Ratio of 0.16. This is a bad value and indicates that DMYY is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
DMYY Yearly Current Assets VS Current LiabilitesDMYY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 500K 1M 1.5M 2M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 95.63% over the past year.
EPS 1Y (TTM)95.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%503.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DMYY Yearly Revenue VS EstimatesDMYY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023
DMYY Yearly EPS VS EstimatesDMYY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
DMYY Price Earnings VS Forward Price EarningsDMYY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DMYY Per share dataDMYY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DMYY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DMY SQUARED TECHNOLOGY GR-A

NYSEARCA:DMYY (3/7/2025, 8:20:03 PM)

After market: 11.15 +0.06 (+0.54%)

11.09

+0.06 (+0.54%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners88.29%
Inst Owner Change-0.45%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap43.47M
AnalystsN/A
Price TargetN/A
Short Float %0.08%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.27
P/tB 2.27
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0
BVpS4.88
TBVpS4.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.2%
ROE 1.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 3.42
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%503.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.9%
OCF growth 3YN/A
OCF growth 5YN/A